Click Here for 5% Off Your First Aladdin Purchase!

Cyclosporin A - 98%, high purity , Cyclophilin A modulator, CAS No.59865-13-3, Cyclophilin A modulator

  • Moligand™
  • ≥98%
Item Number
C106893
Grouped product items
SKUSizeAvailabilityPrice Qty
C106893-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$17.90
C106893-250mg
250mg
In stock
$132.90
C106893-1g
1g
In stock
$477.90
C106893-5g
5g
In stock
$2,150.90
C106893-25g
25g
In stock
$9,677.90
C106893-100g
100g
In stock
$34,838.90

PP2B inhibitor

Basic Description

Synonymscyclosporin A|cyclosporine|Ciclosporin|59865-13-3|Cyclosporin|Sandimmune|Cyclosporine A|Neoral|Sandimmun|Ramihyphin A|Ciclosporine|Equoral|Gengraf|Neoplanta|Sang-35|Ciclosporinum|Sandimmun Neoral|Zinograf ME|Ciclosporina|Consupren|Mitogard|Optimmune|Ciclo
Specifications & PurityMoligand™, ≥98%
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Action TypeANTAGONIST, INHIBITOR, MODULATOR
Mechanism of actionCyclophilin A modulator
Note25mg卖完停产,不再备货

Product Properties

ALogP7.5

Associated Targets

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD2 Tclin D(2) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD4 Tchem D(4) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ELANE Tclin Neutrophil elastase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EGFR Tclin Epidermal growth factor receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HMGCR Tclin 3-hydroxy-3-methylglutaryl-coenzyme A reductase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH1 Tclin Histamine H1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A4 Tclin Sodium-dependent serotonin transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SIGMAR1 Tclin Sigma non-opioid intracellular receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PIK3CG Tclin Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS1 Tclin Prostaglandin G/H synthase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

RARB Tclin Retinoic acid receptor beta 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

RARA Tclin Retinoic acid receptor alpha 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CA2 Tclin Carbonic anhydrase 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD3 Tclin D(3) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2B Tclin Alpha-2B adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2C Tclin Alpha-2C adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2A Tclin 5-hydroxytryptamine receptor 2A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA2A Tclin Adenosine receptor A2a 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ACHE Tclin Acetylcholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR7 Tclin 5-hydroxytryptamine receptor 7 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1A Tclin Alpha-1A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AKR1B1 Tclin Aldose reductase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA1 Tclin Adenosine receptor A1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1A Tclin 5-hydroxytryptamine receptor 1A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA3 Tchem Adenosine receptor A3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR3A Tclin 5-hydroxytryptamine receptor 3A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR6 Tchem 5-hydroxytryptamine receptor 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2B Tclin 5-hydroxytryptamine receptor 2B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

BCHE Tclin Cholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EDNRA Tclin Endothelin-1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EDNRB Tclin Endothelin receptor type B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRD1 Tclin Delta-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRK1 Tclin Kappa-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NOS2 Tchem Nitric oxide synthase, inducible 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TACR1 Tclin Substance-P receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NOS1 Tchem Nitric oxide synthase, brain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MTOR Tclin Serine/threonine-protein kinase mTOR 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
INCHI InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1
InChi Key PMATZTZNYRCHOR-CGLBZJNRSA-N
Canonical SMILES CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
Isomeric SMILES CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
WGK Germany 3
RTECS GZ4120000
PubChem CID 5284373
Molecular Weight 1202.61
Beilstein 3647785
Reaxy-Rn 3647785

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

21 results found

Lot NumberCertificate TypeDateItem
C2429248Certificate of AnalysisMar 09, 2024 C106893
C2429249Certificate of AnalysisMar 09, 2024 C106893
C2429250Certificate of AnalysisMar 09, 2024 C106893
I2313278Certificate of AnalysisAug 16, 2023 C106893
E2406032Certificate of AnalysisAug 16, 2023 C106893
I2313277Certificate of AnalysisAug 16, 2023 C106893
I2313276Certificate of AnalysisAug 16, 2023 C106893
I2313275Certificate of AnalysisAug 16, 2023 C106893
I2313274Certificate of AnalysisAug 16, 2023 C106893
I2313273Certificate of AnalysisAug 16, 2023 C106893
I2313272Certificate of AnalysisAug 16, 2023 C106893
I2313271Certificate of AnalysisAug 16, 2023 C106893
L22151184Certificate of AnalysisDec 30, 2022 C106893
H2321107Certificate of AnalysisJun 01, 2022 C106893
H2303083Certificate of AnalysisJun 01, 2022 C106893
F2224294Certificate of AnalysisJun 01, 2022 C106893
F2224248Certificate of AnalysisJun 01, 2022 C106893
F2224094Certificate of AnalysisJun 01, 2022 C106893
F2224093Certificate of AnalysisJun 01, 2022 C106893
E1803092Certificate of AnalysisMar 30, 2022 C106893
C1810010Certificate of AnalysisJan 21, 2022 C106893

more

Chemical and Physical Properties

SolubilityVery soluble in Ether,Acetone,Methanol,Ethanol; Soluble in Chloroform
Sensitivityheat sensitive ; light sensitive
Specific Rotation[α]-193 ° (C=0.5, MeOH)
Melt Point(°C)151°C

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS07
Signal Danger
Hazard Statements

H302:Harmful if swallowed

H372:Causes damage to organs through prolonged or repeated exposure

H360:May damage fertility or the unborn child

H350:May cause cancer

Precautionary Statements

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P203:Obtain, read and follow all safety instructions before use.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

P319:Get medical help if you feel unwell.

WGK Germany 3
RTECS GZ4120000
Reaxy-Rn 3647785
Merck Index 2752

Related Documents

References

1. Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL.  (1991)  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes..  Cell,  66  (4): (807-15).  [PMID:1715244]
2. Hartz AMS et al..  (2018)  Preventing P-gp Ubiquitination Lowers Aß Brain Levels in an Alzheimer's Disease Mouse Model..  Front Aging Neurosci,  10  (186).  [PMID:29997495]
3. Ding Y et al..  (2021)  Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model..  Fluids Barriers CNS,  18  (10).  [PMID:33676539]
4. Stassart RM et al..  (2013)  A role for Schwann cell-derived neuregulin-1 in remyelination..  Nat Neurosci,  16  (48-54).  [PMID:23222914]
5. Li Z et al..  (2017)  Calcineurin/nuclear factor-?B signaling mediates isoflurane-induced hippocampal neuroinflammation and subsequent cognitive impairment in aged rats..  Mol Med Rep,  15  (201-209).  [PMID:27909728]
6. Zhang MJ et al..  (2020)  CD38 triggers inflammasome-mediated pyroptotic cell death in head and neck squamous cell carcinoma..  Am J Cancer Res,  10  (9): (2895-2908).  [PMID:33042624]
7. Passioura T et al..  (2018)  De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry..  Cell Chem Biol,  25  (7): (906-915.e5).  [PMID:29779957]
8. Choi SY et al..  (2019)  Crlz-1 Controls Germinal Center Reaction by Relaying a Wnt Signal to the Bcl-6 Expression in Centroblasts during Humoral Immune Responses..  J Immunol,  203  (10): (2630-2643).  [PMID:31586036]
9. Matsubara (???) Y et al..  (2021)  Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation..  Arterioscler Thromb Vasc Biol,  41  (3): (e160-e174).  [PMID:33472405]
10. Alassaf M et al..  (2019)  Pregnancy-associated plasma protein-aa supports hair cell survival by regulating mitochondrial function..  Elife,    [PMID:31205004]
11. Kumar S et al..  (2015)  Peptides as skin penetration enhancers: mechanisms of action..  J Control Release,  199  (168-78).  [PMID:25499919]
12. Luo X et al..  (2018)  SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A..  J Virol,  92  (13):   [PMID:29643244]
13. Liao Z et al..  (2022)  The Degradation of TMEM166 by Autophagy Promotes AMPK Activation to Protect SH-SY5Y Cells Exposed to MPP..  Cells,  11  (17):   [PMID:36078115]
14. Xie Y et al..  (2019)  Ultrasound Molecular Imaging of Lymphocyte-endothelium Adhesion Cascade in Acute Cellular Rejection of Cardiac Allografts..  Transplantation,  103  (8): (1603-1611).  [PMID:31343564]
15. Wagner J, von Matt P, Sedrani R, Albert R, Cooke N, Ehrhardt C, Geiser M, Rummel G, Stark W, Strauss A et al..  (2009)  Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes..  J Med Chem,  52  (20): (6193-6).  [PMID:19827831]
16. Heo SJ et al..  (2015)  Biophysical Regulation of Chromatin Architecture Instills a Mechanical Memory in Mesenchymal Stem Cells..  Sci Rep,  (16895).  [PMID:26592929]
17. Santana L et al..  (2008)  Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors..  J Med Chem,  51  (21): (6740-51).  [PMID:18834112]
18. Jean-François Guichou,Julien Viaud,Clément Mettling,Guy Subra,Yea-Lih Lin,Alain Chavanieu.  (2006-02-03)  Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A..  Journal of medicinal chemistry,  49  ((3)): (900-910).  [PMID:16451056]
19. T M Pereira,A P Vieira,J C Fernandes,A Sousa-Basto.  (2006-07-14)  Cyclosporin A treatment in severe childhood psoriasis..  Journal of the European Academy of Dermatology and Venereology : JEADV,  20  ((6)): (651-656).  [PMID:16836490]
20. Y Gong,E Christensen,C Gluud.  (2007-07-20)  Cyclosporin A for primary biliary cirrhosis..  The Cochrane database of systematic reviews,    ((3)): (CD005526-CD005526).  [PMID:17636804]
21. Mauro Galeazzi,Francesca Bellisai,Chiara Giannitti,Stefania Manganelli,Gabriella Morozzi,Gian Domenico Sebastiani.  (2007-10-04)  Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection..  Annals of the New York Academy of Sciences,  1110  (544-549).  [PMID:17911470]
22. Lihong Zhang,Jia Yu,Heling Pan,Ping Hu,Yan Hao,Wenqing Cai,Hong Zhu,Albert D Yu,Xin Xie,Dawei Ma,Junying Yuan.  (2007-11-21)  Small molecule regulators of autophagy identified by an image-based high-throughput screen..  Proceedings of the National Academy of Sciences of the United States of America,  104  ((48)): (19023-19028).  [PMID:18024584]
23. Qing-Li He,Hui Jiang,Feng Zhang,Hai-Bao Chen,Gong-Li Tang.  (2008-06-24)  Simultaneous identification of multiple receptors of natural product using an optimized cDNA phage display cloning..  Bioorganic & medicinal chemistry letters,  18  ((14)): (3995-3998).  [PMID:18571405]
24. Anne Pick,Henrik Müller,Michael Wiese.  (2008-08-06)  Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2)..  Bioorganic & medicinal chemistry,  16  ((17)): (8224-8236).  [PMID:18678495]
25. Guo-Biao Liu,Jian-Liang Xu,Cui-Cui He,Gong Chen,Qiang Xu,Hong-Xi Xu,Jian-Xin Li.  (2009-07-15)  Synthesis and evaluation of a novel series of quinoline derivatives with immunosuppressive activity..  Bioorganic & medicinal chemistry,  17  ((15)): (5433-5441).  [PMID:19596582]
26. Jing Yuan,Ronald L Johnson,Ruili Huang,Jennifer Wichterman,Hongying Jiang,Karen Hayton,David A Fidock,Thomas E Wellems,James Inglese,Christopher P Austin,Xin-zhuan Su.  (2009-09-08)  Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum..  Nature chemical biology,  ((10)): (765-771).  [PMID:19734910]
27. Manthena V S Varma,R Scott Obach,Charles Rotter,Howard R Miller,George Chang,Stefanus J Steyn,Ayman El-Kattan,Matthew D Troutman.  (2010-01-15)  Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination..  Journal of medicinal chemistry,  53  ((3)): (1098-1108).  [PMID:20070106]
28. Xiaoling Puyang,Danielle L Poulin,Joanna E Mathy,Leah J Anderson,Sue Ma,Zheng Fang,Shejin Zhu,Kai Lin,Roger Fujimoto,Teresa Compton,Brigitte Wiedmann.  (2010-02-24)  Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors..  Antimicrobial agents and chemotherapy,  54  ((5)): (1981-1987).  [PMID:20176894]
29. Pu Yong Zhang,Iris L K Wong,Clare S W Yan,Xiao Yu Zhang,Tao Jiang,Larry M C Chow,Sheng Biao Wan.  (2010-06-22)  Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells..  Journal of medicinal chemistry,  53  ((14)): (5108-5120).  [PMID:20560605]
30. Mi-Yeon Jang,Yuan Lin,Steven De Jonghe,Ling-Jie Gao,Bart Vanderhoydonck,Mathy Froeyen,Jef Rozenski,Jean Herman,Thierry Louat,Kristien Van Belle,Mark Waer,Piet Herdewijn.  (2010-12-22)  Discovery of 7-N-piperazinylthiazolo[5,4-d]pyrimidine analogues as a novel class of immunosuppressive agents with in vivo biological activity..  Journal of medicinal chemistry,  54  ((2)): (655-668).  [PMID:21171614]
31. Hae-Rim Kim,Kyoung-Woon Kim,Hong Geun Jung,Kwang-Sup Yoon,Hye-Jwa Oh,Mi-La Cho,Sang-Heon Lee.  (2011-03-16)  Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis..  Arthritis research & therapy,  13  ((2)): (R43-R43).  [PMID:21401926]
32. Minjun Chen,Vikrant Vijay,Qiang Shi,Zhichao Liu,Hong Fang,Weida Tong.  (2011-06-01)  FDA-approved drug labeling for the study of drug-induced liver injury..  Drug discovery today,  16  ((15-16)): (697-703).  [PMID:21624500]
33. Zhichao Liu,Qiang Shi,Don Ding,Reagan Kelly,Hong Fang,Weida Tong.  (2011-12-24)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)..  PLoS computational biology,  ((12)): (e1002310-e1002310).  [PMID:22194678]
34. Hiroyuki Uchino,Kiyoshi Hatakeyama,Saori Morota,Tadashi Tanoue,Takahisa Nishiyama,Daiki Usui,Chisato Taguchi,Morika Suzuki,Magnus J Hansson,Eskil Elmér.  (2013-07-24)  Cyclophilin-D inhibition in neuroprotection: dawn of a new era of mitochondrial medicine..  Acta neurochirurgica. Supplement,  118  (311-315).  [PMID:23564156]
35. G Hodge,S Hodge,J Ahern,C-L Holmes-Liew,P N Reynolds,M Holmes.  (2013-04-24)  Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome..  Clinical and experimental immunology,  173  ((1)): (150-160).  [PMID:23607447]
36. Wolfgang Arns,Claudia Sommerer,Petra Glander,Toofan Ariatabar,Martina Porstner,Christoph May,Eva-Maria Paulus,Maria Shipkova,Wolfgang Fischer,Lutz Liefeldt,Ruth Hackenberg,Peter Schemmer,Sophie Domhan,Martin Zeier,Klemens Budde.  (2013-04-25)  A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year..  Clinical nephrology,  79  ((6)): (421-431).  [PMID:23611518]
37. M Roy First, Shobha Dhadda, Richard Croy, John Holman, William E Fitzsimmons.  (2013-04-27)  New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials..  Transplantation,  96  ((1)): (58-64).  [PMID:23619735]
38. Pakit Vichyanond,Panida Kosrirukvongs.  (2013-04-30)  Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis..  Current allergy and asthma reports,  13  ((3)): (308-314).  [PMID:23625179]
39. Manisha Sahay,Rakesh K Sahay,Girish Narayan.  (2013-09-14)  New-onset diabetes after transplantation--role of oral glucose tolerance test for diagnosis and study of risk factors..  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,  24  ((5)): (897-902).  [PMID:24029252]
40. Cuiping Yang,Tianhong Zhang,Zheng Li,Liang Xu,Fei Liu,Jinxiu Ruan,Keliang Liu,Zhenqing Zhang.  (2013-10-15)  P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies..  Toxicology and applied pharmacology,  273  ((3)): (561-568).  [PMID:24120885]
41. Sule Unal,Erdal Sag,Baris Kuskonmaz,Selman Kesici,Benan Bayrakci,Deniz C Ayvaz,Ilhan Tezcan,Dilek Yalnızoglu,Duygu Uckan.  (2013-12-07)  Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab..  Pediatric blood & cancer,  61  ((5)): (928-930).  [PMID:24307660]
42. Myew-Ling Toh,Jean-Yves Bonnefoy,Nathalie Accart,Sandrine Cochin,Sandy Pohle,Hélène Haegel,Micael De Meyer,Christophe Zemmour,Xavier Preville,Christine Guillen,Christine Thioudellet,Philippe Ancian,Anja Lux,Bettina Sehnert,Falk Nimmerjahn,Reinhard E Voll,Georg Schett.  (2014-03-14)  Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis..  Arthritis & rheumatology (Hoboken, N.J.),  66  ((11)): (2989-3000).  [PMID:24623505]
43. Mir-Jamal Hosseini,Fatemeh Shaki,Mahmoud Ghazi-Khansari,Jalal Pourahmad.  (2014-04-03)  Toxicity of copper on isolated liver mitochondria: impairment at complexes I, II, and IV leads to increased ROS production..  Cell biochemistry and biophysics,  70  ((1)): (367-381).  [PMID:24691927]
44. Robert Sidbury,Dawn M Davis,David E Cohen,Kelly M Cordoro,Timothy G Berger,James N Bergman,Sarah L Chamlin,Kevin D Cooper,Steven R Feldman,Jon M Hanifin,Alfons Krol,David J Margolis,Amy S Paller,Kathryn Schwarzenberger,Robert A Silverman,Eric L Simpson,Wynnis L Tom,Hywel C Williams,Craig A Elmets,Julie Block,Christopher G Harrod,Wendy Smith Begolka,Lawrence F Eichenfield.  (2014-05-13)  Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents..  Journal of the American Academy of Dermatology,  71  ((2)): (327-349).  [PMID:24813298]
45. Xinying Jia,Hong Zhang,Xu Cao,Yuxin Yin,Bo Zhang.  (2014-06-17)  Activation of TRPV1 mediates thymic stromal lymphopoietin release via the Ca2+/NFAT pathway in airway epithelial cells..  FEBS letters,  588  ((17)): (3047-3054).  [PMID:24931369]
46. Konrad Meissner,Jane Blood,Amber M Francis,Viktar Yermolenka,Evan D Kharasch.  (2014-07-30)  Cyclosporine-inhibitable cerebral drug transport does not influence clinical methadone pharmacodynamics..  Anesthesiology,  121  ((6)): (1281-1291).  [PMID:25072223]
47. Zhe Gao,Yuxiang Ma,Dan Zhao,Xiong Zhang,Hang Zhou,Hailiang Liu,Yang Zhou,Xuefeng Wu,Yan Shen,Yang Sun,Jianxin Li,Xudong Wu,Qiang Xu.  (2014-09-15)  Neochromine S5 improves contact hypersensitivity through a selective effect on activated T lymphocytes..  Biochemical pharmacology,  92  ((2)): (358-368).  [PMID:25218598]
48. Gilles Safa,Karine Luce,Laure Darrieux,Laurent Tisseau,Nicolas Ortonne.  (2014-09-16)  Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy..  Journal of the American Academy of Dermatology,  71  ((4)): (e149-e150).  [PMID:25219741]
49. Sami Akbulut,Hulya Elbe,Cengiz Eris,Zumrut Dogan,Gulten Toprak,Erhan Yalcin,Emrah Otan,Yusuf Turkoz.  (2014-10-05)  Effects of antioxidant agents against cyclosporine-induced hepatotoxicity..  The Journal of surgical research,  193  ((2)): (658-666).  [PMID:25281288]
50. Kambiz N Alavian,Steven I Dworetzky,Laura Bonanni,Ping Zhang,Silvio Sacchetti,Hongmei Li,Armando P Signore,Peter J S Smith,Valentin K Gribkoff,Elizabeth A Jonas.  (2014-10-22)  The mitochondrial complex V-associated large-conductance inner membrane current is regulated by cyclosporine and dexpramipexole..  Molecular pharmacology,  87  ((1)): (1-8).  [PMID:25332381]
51. Xu Li,Feng Zhu,Jianxin Jiang,Chengyi Sun,Xin Wang,Ming Shen,Rui Tian,Chengjian Shi,Meng Xu,Feng Peng,Xingjun Guo,Min Wang,Renyi Qin.  (2014-12-03)  Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells..  Cancer letters,  357  ((1)): (219-230).  [PMID:25444914]
52. Megan D Lee,Kellie N Bingham,Taylor Y Mitchell,Jenna L Meredith,Jason S Rawlings.  (2014-12-03)  Calcium mobilization is both required and sufficient for initiating chromatin decondensation during activation of peripheral T-cells..  Molecular immunology,  63  ((2)): (540-549).  [PMID:25453467]
53. Janine Müller,Christiana Ossig,Johannes F W Greiner,Stefan Hauser,Mareike Fauser,Darius Widera,Christian Kaltschmidt,Alexander Storch,Barbara Kaltschmidt.  (2014-12-07)  Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats..  Stem cells translational medicine,  ((1)): (31-43).  [PMID:25479965]
54. Christina A Clarke,Hilary A Robbins,Zaria Tatalovich,Charles F Lynch,Karen S Pawlish,Jack L Finch,Brenda Y Hernandez,Joseph F Fraumeni,Margaret M Madeleine,Eric A Engels.  (2015-01-13)  Risk of merkel cell carcinoma after solid organ transplantation..  Journal of the National Cancer Institute,  107  ((2)): (doi:10-doi:10).  [PMID:25575645]
55. Shengjun Nie,Haiyun Yue,Jun Zhou,Da Xing.  (2015-03-27)  Mitochondrial-derived reactive oxygen species play a vital role in the salicylic acid signaling pathway in Arabidopsis thaliana..  PloS one,  10  ((3)): (e0119853-e0119853).  [PMID:25811367]
56. Yang Zhou,Deming Zhao,Ruichao Yue,Sher Hayat Khan,Syed Zahid Ali Shah,Xiaomin Yin,Lifeng Yang,Zhongqiu Zhang,Xiangmei Zhou.  (2015-05-20)  Inflammasomes-dependent regulation of IL-1β secretion induced by the virulent Mycobacterium bovis Beijing strain in THP-1 macrophages..  Antonie van Leeuwenhoek,  108  ((1)): (163-171).  [PMID:25980833]
57. Jiali Wan,Jia-Hong Wang,Ting Liu,Zhixiong Xie,Xue-Feng Yu,Wenhua Li.  (2015-06-23)  Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo..  Scientific reports,  (11398-11398).  [PMID:26096816]
58. Bo Ma,Jia Yu,Chengsong Xie,Lixin Sun,Shannon Lin,Jinhui Ding,Jing Luo,Huaibin Cai.  (2015-08-01)  Toll-Like Receptors Promote Mitochondrial Translocation of Nuclear Transcription Factor Nuclear Factor of Activated T-Cells in Prolonged Microglial Activation..  The Journal of neuroscience : the official journal of the Society for Neuroscience,  35  ((30)): (10799-10814).  [PMID:26224862]
59. Patrick G Miller,Michael B Bonn,Susan C McKarns.  (2015-08-14)  Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression..  Journal of immunology (Baltimore, Md. : 1950),  195  ((6)): (2633-2647).  [PMID:26268655]
60. Alexander I Bondarenko,Warisara Parichatikanond,Corina T Madreiter,Rene Rost,Markus Waldeck-Weiermair,Roland Malli,Wolfgang F Graier.  (2015-08-16)  UCP2 modulates single-channel properties of a MCU-dependent Ca(2+) inward current in mitochondria..  Pflugers Archiv : European journal of physiology,  467  ((12)): (2509-2518).  [PMID:26275882]
61. Paloma Gómez-Fernández,Andoni Urtasun,Ianire Astobiza,Jorge Mena,Iraide Alloza,Koen Vandenbroeck.  (2019-05-22)  Pharmacological Targeting of the ER-Resident Chaperones GRP94 or Cyclophilin B Induces Secretion of IL-22 Binding Protein Isoform-1 (IL-22BPi1)..  International journal of molecular sciences,  20  ((10)):   [PMID:31108847]
62. Angela C Webster,Rebecca C Woodroffe,Rod S Taylor,Jeremy R Chapman,Jonathan C Craig.  (2005-09-15)  Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data..  BMJ (Clinical research ed.),  331  ((7520)): (810-810).  [PMID:16157605]
63. John Berth-Jones.  (2006-01-24)  The use of ciclosporin in psoriasis..  The Journal of dermatological treatment,  16  ((5-6)): (258-277).  [PMID:16428145]
64. Pieter Van de Vijver,Tomasz Ostrowski,Brian Sproat,Jozef Goebels,Omer Rutgeerts,Arthur Van Aerschot,Mark Waer,Piet Herdewijn.  (2008-04-29)  Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants..  Journal of medicinal chemistry,  51  ((10)): (3020-3029).  [PMID:18438987]
65. Nicola Antonio Colabufo,Francesco Berardi,Marialessandra Contino,Carmela Inglese,Mauro Niso,Roberto Perrone.  (2008-06-06)  Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum..  Bioorganic & medicinal chemistry letters,  18  ((13)): (3741-3744).  [PMID:18524592]
66. Stefan Leyers,Hans-Georg Häcker,Jeanette Wiendlocha,Michael Gütschow,Michael Wiese.  (2008-08-19)  A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteins..  Bioorganic & medicinal chemistry letters,  18  ((17)): (4761-4763).  [PMID:18707884]
67. Werner Klinkhammer,Henrik Müller,Christoph Globisch,Ilza K Pajeva,Michael Wiese.  (2009-03-03)  Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators..  Bioorganic & medicinal chemistry,  17  ((6)): (2524-2535).  [PMID:19250834]
68. Kelly E Desino,Sabah Ansar,Gunda I Georg,Richard H Himes,Mary Lou Michaelis,Douglas R Powell,Emily A Reiff,Hanumaiah Telikepalli,Kenneth L Audus.  (2009-09-05)  (3R,5S,7as)-(3,5-Bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol, a novel neuroprotective agent..  Journal of medicinal chemistry,  52  ((23)): (7537-7543).  [PMID:19728715]
69. Dzenan Lulic,Jack Burns,Eunkyung Cate Bae,Harry van Loveren,Cesar V Borlongan.  (2011-02-11)  A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury..  Neurosurgery,  68  ((5)): (1172-1185).  [PMID:21307793]
70. Burçin Yavuz,Sibel Bozdağ Pehlivan,Nurşen Unlü.  (2012-05-24)  An overview on dry eye treatment: approaches for cyclosporin a delivery..  TheScientificWorldJournal,  2012  (194848-194848).  [PMID:22619624]
71. Zhenjie Chen,Xin Du.  (2013-06-26)  Immunosuppression for membranous nephropathy..  Lancet (London, England),  381  ((9884)): (2162-2163).  [PMID:23791339]
72. Frank Peinemann,Carmen Bartel,Ulrich Grouven.  (2013-07-25)  First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia..  The Cochrane database of systematic reviews,  ((7)): (CD006407-CD006407).  [PMID:23881658]
73. Chiara Giannitti,Irene Fineschi,Bruno Frediani,Antonella Fioravanti,Mauro Galeazzi.  (2013-09-12)  Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection..  Clinical and experimental rheumatology,  31  ((5)): (816-816).  [PMID:24021246]
74. Jennifer A Faralli,Debjani Gagen,Mark S Filla,Tania N Crotti,Donna M Peters.  (2013-10-09)  Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway..  Biochimica et biophysica acta,  1833  ((12)): (3306-3313).  [PMID:24100160]
75. Dj Hausenloy,G Kunst,E Boston-Griffiths,S Kolvekar,S Chaubey,L John,J Desai,Dm Yellon.  (2014-02-04)  The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial..  Heart (British Cardiac Society),  100  ((7)): (544-549).  [PMID:24488610]
76. Sulyi Kim,Tomoko Date,Hiroshi Yokokawa,Tamaki Kono,Hideki Aizaki,Patrick Maurel,Claire Gondeau,Takaji Wakita.  (2014-05-07)  Development of hepatitis C virus genotype 3a cell culture system..  Hepatology (Baltimore, Md.),  60  ((6)): (1838-1850).  [PMID:24797787]
77. Haining He,Hong Huang,Tinghe Yu.  (2014-05-16)  Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay..  International journal of radiation biology,  90  ((10)): (897-902).  [PMID:24827854]
78. Christopher Abela,Christoph E A Hartmann,A De Leo,Anna de Sica Chapman,Hetul Shah,Mohammad Jawad,Christopher B Bunker,Greg J P Williams,Jorge Leon-Villapalos.  (2014-05-28)  Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm..  Journal of plastic, reconstructive & aesthetic surgery : JPRAS,  67  ((8)): (1026-1032).  [PMID:24860933]
79. Chang-Kwon Oh,Kyu Ha Huh,Jongwon Ha,Yeong Hoon Kim,Yong-Lim Kim,Yu Seun Kim.  (2014-07-02)  Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients..  Transplantation,  99  ((1)): (180-186).  [PMID:24983307]
80. Yan Qin,Yu Fan,XingYu Mu,Fang Zhang,Bing Shen,Yong Liu,YiFeng Guo,Yong Wang,Jianxin Qiu.  (2014-07-31)  Long-term use of ciclosporin on kidney transplant recipients surviving more than 10 years..  Die Pharmazie,  69  ((7)): (558-560).  [PMID:25073404]
81. Yibo Zhuang,Marchella Yasinta,Caiyu Hu,Min Zhao,Guixia Ding,Mi Bai,Lingyun Yang,Jiajia Ni,Rong Wang,Zhanjun Jia,Songming Huang,Aihua Zhang.  (2015-02-20)  Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury..  American journal of physiology. Renal physiology,  308  ((8)): (F857-F866).  [PMID:25694478]
82. Marta Grabowska,Sylwia Słuczanowska-Głąbowska,Andrzej Kram,Leszek Teresiński,Małgorzata Piasecka,Marzenna Podhorska-Okołów,Iwona Rotter,Karolina Kędzierska,Katarzyna Sporniak-Tutak,Kazimierz Ciechanowski,Maria Laszczyńska.  (2015-03-17)  The influence of immunosuppressants on the morphology, proliferating cell nuclear antigen (PCNA) and apoptosis in the rat ventral prostate..  Histology and histopathology,  30  ((9)): (1089-1100).  [PMID:25772584]
83. Pengyun Li,Xingmin Wang,Ming Zhao,Rui Song,Ke-Seng Zhao.  (2015-06-16)  Polydatin protects hepatocytes against mitochondrial injury in acute severe hemorrhagic shock via SIRT1-SOD2 pathway..  Expert opinion on therapeutic targets,  19  ((7)): (997-1010).  [PMID:26073907]
84. Jungang Nie,Na Ta,Lijuan Liu,Guoxiang Shi,Ting Kang,Zeqi Zheng.  (2019-10-22)  Activation of CaMKII via ER-stress mediates coxsackievirus B3-induced cardiomyocyte apoptosis..  Cell biology international,  44  ((2)): (488-498).  [PMID:31631456]
85. M Hossein Aghdaie,N Azarpira,A Shamsaeefar,N Motazedian,M Kaviani,E Esfandiari,S Golbabapour,S Nikeghbalian,K Kazemi,H Salahi,S A Malek-Hosseini,B Geramizadeh.  (2020-12-17)  Effects of Different Cold Preservation Solutions on the Functions of Cultured Isolated Human Hepatocytes..  International journal of organ transplantation medicine,  11  ((1)): (15-25).  [PMID:33324474]

Solution Calculators